{
  "meta": {
    "title": "Drugs_Acting_In_Gi_System",
    "url": "https://brainandscalpel.vercel.app/drugs-acting-in-gi-system-b01102e2.html",
    "scrapedAt": "2025-11-30T08:50:54.479Z"
  },
  "questions": [
    {
      "id": 1,
      "choices": [
        {
          "id": 1,
          "text": "<p><span style=\"font-size:12.0pt;\">A proton pump inhibitor, amoxicillin, and clarithromycin</span></p>"
        },
        {
          "id": 2,
          "text": "<p><span style=\"font-size:12.0pt;\">A proton pump inhibitor, bismuth subsalicylate and tetracycline</span></p>"
        },
        {
          "id": 3,
          "text": "<p><span style=\"font-size:12.0pt;\">A histamine H2 blocker, amoxicillin and clarithromycin</span></p>"
        },
        {
          "id": 4,
          "text": "<p><span style=\"font-size:12.0pt;\">A proton pump inhibitor plus sequential administration of amoxicillin followed by clarithromycin and tinidazole</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 56-year-old woman came to the medicine department seeking treatment for a duodenal ulcer caused by H. pylori infection. Her physician has prescribed the fastest effective treatment available. Which of the following drug combinations would most likely achieve this goal?</span></p>",
      "unique_key": "DT1292830",
      "question_audio": null,
      "question_video": null,
      "map_id": 1292830,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>Short-course sequential therapy</strong> consisting of a proton pump inhibitor plus sequential administration of amoxicillin followed by clarithromycin and tinidazole <strong><u>offers a high rate of H. pylori eradication and ulcer healing with greater convenience than many other regimens.</u></strong></li>\r\n</ul>\r\n<p><strong><u>Guidelines for selecting anti-H. pylori regime:</u></strong></p>\r\n<ol>\r\n<li><strong>Combination of 2 or more antibiotics</strong> (single antibiotic increases the risk of resistance)</li>\r\n<li>Add <strong>Proton Pump Inhibitor</strong> (It is better than H2 blocker): Decreasing HCl increases the effect of antibiotics.</li>\r\n<li><strong>Treatment for at least for 10-14 days.</strong></li>\r\n<li><strong>Fixed drug combination</strong> (combine all drugs in a single tablet)</li>\r\n</ol>\r\n<p><strong><u>Benefit of treating H. pylori:</u></strong></p>\r\n<ol>\r\n<li>Decreases the risk of H. pylori</li>\r\n<li>Decreases the risk of GERD</li>\r\n</ol>\r\n<p><strong><u>Regimens:</u></strong></p>\r\n<p><strong>Triple therapy is the regimen of choice.</strong></p>\r\n<p>It includes</p>\r\n<ul>\r\n<li><strong><u>Mnemonic [CAP]</u></strong>\r\n<ul>\r\n<li><strong>P</strong>: Proton Pump Inhibitor</li>\r\n<li><strong>C</strong>: Clarithromycin &amp;</li>\r\n<li><strong>A</strong>: Amoxicillin or M: Metronidazole/Tinidazole</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p>Quadruple therapy is used in case of resistance which incorporates</p>\r\n<ul>\r\n<li><strong><u>Mnemonic [PMBT] </u></strong>\r\n<ul>\r\n<li><strong>P</strong>roton Pump Inhibitor</li>\r\n<li><strong>M</strong>etronidazole,</li>\r\n<li><strong>B</strong>ismuth &amp;</li>\r\n<li><strong>T</strong>etracycline</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong><u>Key Takeaway:</u></strong></p>\r\n<ul>\r\n<li><strong>Short-course sequential therapy</strong> consisting of a proton pump inhibitor plus sequential administration of amoxicillin followed by clarithromycin and tinidazole <strong>offers a high rate of H. pylori eradication and ulcer healing with greater convenience than many other regimens.</strong></li>\r\n</ul>",
      "correct_choice_id": 4,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2,
      "choices": [
        {
          "id": 11,
          "text": "<p><span style=\"font-size:12.0pt;\">Hyperglycemia</span></p>"
        },
        {
          "id": 12,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypercalcemia</span></p>"
        },
        {
          "id": 13,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypokalemia</span></p>"
        },
        {
          "id": 14,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypophosphatemia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 65-year-old woman suffering from chronic heartburn was routinely taking a large amount of an antacid preparation containing aluminum hydroxide by her own. Laboratory examinations of this patient would most likely show which of the following results of blood samples?</span></p>",
      "unique_key": "DT1293070",
      "question_audio": null,
      "question_video": null,
      "map_id": 1293070,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>Aluminum salts bind phosphate in the gut, preventing phosphate absorption.</strong></li>\r\n<li>Moreover, they can induce a blood to gut phosphorus gradient that <strong>favors the elimination of circulating phosphate</strong>.</li>\r\n<li>In fact, <strong>chronic use of high doses of aluminum salts is one of the common causes of hypophosphatemia.</strong></li>\r\n<li>Sustained use of antacids, however, can <strong>severely limit phosphate absorption and result in clinical phosphate depletion</strong>, manifest as <u>malaise, muscle weakness, and osteomalacia</u>.</li>\r\n<li><strong>Osteomalacia is characterized by undermineralized bone matrix and may occur when sustained phosphate depletion</strong> is caused by inhibiting its absorption in the GI tract (as with aluminum-containing antacids)</li>\r\n</ul>\r\n<p><strong><u>Key Takeaway:</u></strong></p>\r\n<ul>\r\n<li>Aluminum salts bind phosphate in the gut, preventing phosphate absorption causing <u>hypophoshatemia if used chronically</u>.</li>\r\n</ul>",
      "correct_choice_id": 14,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3,
      "choices": [
        {
          "id": 21,
          "text": "<p><span style=\"font-size:12.0pt;\">Famotidine</span></p>"
        },
        {
          "id": 22,
          "text": "<p><span style=\"font-size:12.0pt;\">Lansoprazole</span></p>"
        },
        {
          "id": 23,
          "text": "<p><span style=\"font-size:12.0pt;\">Misoprostol</span></p>"
        },
        {
          "id": 24,
          "text": "<p><span style=\"font-size:12.0pt;\">Propantheline</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 67-year-old man came to medicine department for follow up over multiple visits for complaints of ulcers, despite the use of ranitidine. Further laboratory studies, finding elevated levels of gastrin and evidence of ulcers involving the jejunum, suggest a diagnosis of Zollinger-Ellison syndrome. Which of the following agents would be most useful in the management of this patient?</span></p>",
      "unique_key": "DT1293073",
      "question_audio": null,
      "question_video": null,
      "map_id": 1293073,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>Lansoprazole is a proton pump inhibitor useful in the treatment of patients who have <u>failed histamine H2-blocker therapy and patients with Zollinger-Ellison syndrome.</u></strong></li>\r\n</ul>\r\n<p><strong><u>Zollinger-Ellison syndrome:</u></strong></p>\r\n<p>It is a <strong>gastric hypersecretory state due to 'gastrinoma'</strong>, a rare tumour secreting gastrin, which presents with <strong>difficult to heal gastric/duodenal ulcer(s).</strong></p>\r\n<ul>\r\n<li><strong><u>High dose oral Proton pump inhibitor is the drug of choice for controlling symptoms.</u></strong></li>\r\n</ul>\r\n<p><strong><u>Uses of Proton pump inhibitor</u></strong></p>\r\n<ol>\r\n<li><strong>It is a drug of choice for any cause of peptic ulcer including NSAID induced peptic ulcer and H. pylori induced peptic ulcer</strong>.</li>\r\n<li>They are also the <strong>drug of choice for GERD</strong>.\r\n<ul>\r\n<li><u>Prokinetic is added</u> to close lower esophageal sphincter.</li>\r\n<li><strong>Prokinetics include:</strong>\r\n<ol style=\"list-style-type: lower-roman;\">\r\n<li><strong>Domperidone</strong></li>\r\n<li><strong>Mosapride</strong></li>\r\n<li><strong>Levosulpiride</strong></li>\r\n</ol>\r\n</li>\r\n</ul>\r\n</li>\r\n<li>Intravenous PPIs are the <strong>drug of choice for bleeding disorders</strong>.</li>\r\n<li>It is <strong>a drug of choice for Zollinger Ellison Syndrome</strong> (gastrinoma). Octreotide is a somatostatin analogue given in combination with PPI.<br /><strong>Octreotide decreases gastrin production and PPI decrease HCl production</strong> (stimulated by Gastrin).</li>\r\n<li><strong>Aspiration pneumonia</strong> (during surgery)</li>\r\n</ol>\r\n<p><strong>Side effects:</strong></p>\r\n<p>Nausea, Vomiting and diarrhoea: most common</p>\r\n<p><strong>Side effects due to chronic use:</strong> decreased HCl in stomach causes-Decreased absorption of:</p>\r\n<ol style=\"list-style-type: lower-alpha;\">\r\n<li>Iron: anaemia</li>\r\n<li>Calcium: osteoporosis (increased risk of hip fracture in old age people)</li>\r\n<li>Magnesium</li>\r\n</ol>\r\n<p><strong><u>Summary of drugs used for acid-peptic disease</u></strong></p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20241220ce22c9fa-4b63-47ed-b24a-37d195b28999.jpg\">\r\n<p><strong>Options A, C &amp; D:</strong> All of these drugs are not that effective as PPIs to control the symtomps of Zollinger-Ellison syndrome.</p>\r\n<p><strong><u>Key Takeaway:</u></strong></p>\r\n<ul>\r\n<li>High dose oral Proton pump inhibitor is the <u>drug of choice for controlling symptoms of Zollinger-Ellison syndrome</u></li>\r\n</ul>",
      "correct_choice_id": 22,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4,
      "choices": [
        {
          "id": 31,
          "text": "<p><span style=\"font-size:12.0pt;\">30 min</span></p>"
        },
        {
          "id": 32,
          "text": "<p><span style=\"font-size:12.0pt;\">60 min</span></p>"
        },
        {
          "id": 33,
          "text": "<p><span style=\"font-size:12.0pt;\">90 min</span></p>"
        },
        {
          "id": 34,
          "text": "<p><span style=\"font-size:12.0pt;\">120 min</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 56-year-old female patient was stable on phenytoin for seizure disorder. She later visited her physician for peptic ulcer disease and was prescribed sucralfate 4 times a day for peptic ulcer. What should be the minimum duration between consumption of two drugs?</span></p>",
      "unique_key": "DT1293077",
      "question_audio": null,
      "question_video": null,
      "map_id": 1293077,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>Sucralfate forms a <u>viscous layer in the stomach</u> that may inhibit absorption of other drugs, including phenytoin, digoxin, cimetidine, ketoconazole, and fluoroquinolone antibiotics.</strong></li>\r\n<li>Sucralfate therefore <strong>should be taken at least 2 h after the administration of other drugs.</strong></li>\r\n<li>The <strong>\"sticky\" nature of the viscous gel produced by sucralfate in the stomach also may be responsible for the <u>development of bezoars</u> in some patients.</strong></li>\r\n</ul>\r\n<p><strong><u>Sucralfate</u></strong></p>\r\n<p>It is <u>sucrose aluminium sulphate</u>.</p>\r\n<p><strong><u>Uses:</u></strong></p>\r\n<ol>\r\n<li>Peptic ulcer disease</li>\r\n<li>Suppository/enema for rectal ulcers.</li>\r\n<li>Esophageal ulcer</li>\r\n<li>Topical cream for skin ulcer.</li>\r\n</ol>\r\n<p><strong><u>Side effect</u>:</strong></p>\r\n<p>Constipation because aluminium relaxes muscles.</p>\r\n<p><strong><u>There should be a gap</u>:</strong></p>\r\n<ol style=\"list-style-type: upper-alpha;\">\r\n<li>30 minutes with antacids.</li>\r\n<li>1 hour with meals.</li>\r\n<li>2 hours with certain drugs: sticky layer decreases the absorption of certain drugs like:\r\n<ul>\r\n<li><u>Phenytoin</u></li>\r\n<li><u>Cimetidine, Ranitidine</u></li>\r\n<li><u>Digoxin</u></li>\r\n</ul>\r\n</li>\r\n</ol>\r\n<p><strong><u>Key Takeaway:</u></strong></p>\r\n<ul>\r\n<li>Sucralfate should be taken at least 2h after the administration of other drugs because it forms a <u>viscous layer in the stomach</u> that may inhibit absorption of other drugs</li>\r\n</ul>",
      "correct_choice_id": 34,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5,
      "choices": [
        {
          "id": 41,
          "text": "<p><span style=\"font-size:12.0pt;\">Famotidine</span></p>"
        },
        {
          "id": 42,
          "text": "<p><span style=\"font-size:12.0pt;\">Omeprazole</span></p>"
        },
        {
          "id": 43,
          "text": "<p><span style=\"font-size:12.0pt;\">Misoprostol</span></p>"
        },
        {
          "id": 44,
          "text": "<p><span style=\"font-size:12.0pt;\">Ranitidine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 34 years old pregnant woman had a history of rheumatoid arthritis having been managed successfully with NSAIDs. Later she visited medicine opd complaining of burning epigastric pain worsened by food intake. Which of the following ulcer medication is absolutely contraindicated in this patient?</span></p>",
      "unique_key": "DT1293080",
      "question_audio": null,
      "question_video": null,
      "map_id": 1293080,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Misoprostol (methyl-PGE1 ester)</strong> is a longer-acting <strong>synthetic PGE1</strong> derivative which inhibits acid output.</p>\r\n<p>Ulcer healing rates comparable to cimetidine have been obtained in 4-8 weeks, but <strong>misoprostol is poorer in relieving ulcer pain.</strong></p>\r\n<p>Major problems in the use of misoprostol are-<strong>diarrhoea, abdominal cramps, uterine bleeding, <u>abortion</u>, and need for multiple daily doses. Patient acceptability is poor.</strong></p>\r\n<p><strong>The primary indication of misoprostol:</strong></p>\r\n<p>Prevention and treatment of NSAID associated Ulcers. It's most specific drug for the same.</p>\r\n<p><strong>Option A, B &amp; D:</strong></p>\r\n<p>All other drugs including PPIs and H2 receptor blockers can be safely given amongst pregnant females.</p>\r\n<p><strong><u>Key Takeaway:</u></strong></p>\r\n<ul>\r\n<li>Misoprostol is contraindicated in pregnant women because of the risk of abortion and uterine bleeding.</li>\r\n</ul>",
      "correct_choice_id": 43,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6,
      "choices": [
        {
          "id": 51,
          "text": "<p><span style=\"font-size:12.0pt;\">Omeprazole</span></p>"
        },
        {
          "id": 52,
          "text": "<p><span style=\"font-size:12.0pt;\">Lansoprazole</span></p>"
        },
        {
          "id": 53,
          "text": "<p><span style=\"font-size:12.0pt;\">Esomeprazole</span></p>"
        },
        {
          "id": 54,
          "text": "<p><span style=\"font-size:12.0pt;\">Rabeprazole</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 65-year-old male patient with a history of ongoing treatment for tuberculosis presented to the medicine department with complaints of heartburn, abdominal fullness, belching and later diagnosed with Gastro-esophageal reflux disease (GERD). Which of the following proton pump inhibitors can be safely given in this patient?</span></p>",
      "unique_key": "DT1293082",
      "question_audio": null,
      "question_video": null,
      "map_id": 1293082,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Proton pump inhibitors are metabolized by CYP3A4 and CYP2C19</strong>. They are also <strong>inhibitors of these enzymes</strong>.</p>\r\n<p><strong><u>Rabeprazole and pantoprazole has less affinity for these enzymes</u></strong>.</p>\r\n<p><strong><u>Rabeprazole:</u></strong></p>\r\n<ul>\r\n<li>This drug is claimed to <strong>cause faster acid suppression</strong>. Due to <strong>higher pKa, it is more rapidly converted to the active species.</strong></li>\r\n<li>However, potency and efficacy are similar to omeprazole. <strong><u>No significant drug interactions have been observed.</u></strong></li>\r\n</ul>\r\n<p><strong>Option A, B &amp; C:</strong> All others drugs are <strong>significant inhibitors of CYP3A4 and CYP2C19</strong> enzymes</p>\r\n<p><strong><u>Key Takeaway:</u></strong></p>\r\n<ul>\r\n<li><strong>Proton pump inhibitors are metabolized by CYP3A4 and CYP2C19</strong>. They are also <strong>inhibitors of these enzymes. <u>Rabeprazole has less affinity for these enzymes</u></strong> among all PPIs.</li>\r\n</ul>",
      "correct_choice_id": 54,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7,
      "choices": [
        {
          "id": 61,
          "text": "<p><span style=\"font-size:12.0pt;\">Bismuth subsalicylate</span></p>"
        },
        {
          "id": 62,
          "text": "<p><span style=\"font-size:12.0pt;\">Sucralfate</span></p>"
        },
        {
          "id": 63,
          "text": "<p><span style=\"font-size:12.0pt;\">Omeprazole</span></p>"
        },
        {
          "id": 64,
          "text": "<p><span style=\"font-size:12.0pt;\">Cimetidine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following drugs can result in the below condition?<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20241220c95fa3a8-20ab-4f58-ab16-82aecaad7966.jpg\"></span></p>",
      "unique_key": "DT1293083",
      "question_audio": null,
      "question_video": null,
      "map_id": 1293083,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><u>Bismuth subsalicylate:</u></p>\n<p>It is thought to act by decreasing PG synthesis in the intestinal mucosa, thereby reducing Cl<sup>-</sup> secretion.</p>\n<p>It has some prophylactic value in traveller's diarrhoea (probably due to weak antibacterial action as well)</p>\n<p><u>Dark stools</u> (sometimes mistaken for melena) and <u>black staining of the tongue</u> in association with bismuth compounds are caused by bismuth sulfide formed in a reaction between the drug and bacterial sulfides in the GI tract.</p>\n<p><strong>Incorrect options-</strong></p>\n<p><strong>Option B:</strong> Most common side effect of sucralfate is constipation.</p>\n<p><strong>Option C:</strong> PPIs are quite safe drugs and have diarrhea, headache and abdominal pain as adverse effects. Omeprazole and other PPIs inhibit CYP2C19 enzyme and result in Increase/decreased activity of other drugs.</p>\n<p><strong>Option D:</strong> It is a potent inhibitor of CYP enzymes and can increase plasma concentration of warfarin, theophylline and many other drugs. It inhibits metabolism of estradiol and increases serum prolactin levels on long term use, thus can cause gynaecomastia (in males) and galactorrhoea (in females).</p>\n<p><strong><u>Key Takeaway:</u></strong></p>\n<ul>\n<li><u>Black staining of the tongue</u> in association with bismuth compounds are caused by bismuth sulfide.</li>\n</ul>",
      "correct_choice_id": 61,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8,
      "choices": [
        {
          "id": 71,
          "text": "<p><span style=\"font-size:12.0pt;\">To achieve a bactericidal effect on Helicobacter pylori</span></p>"
        },
        {
          "id": 72,
          "text": "<p><span style=\"font-size:12.0pt;\">To avoid antacid overdose toxicity</span></p>"
        },
        {
          "id": 73,
          "text": "<p><span style=\"font-size:12.0pt;\">To facilitate gastric emptying</span></p>"
        },
        {
          "id": 74,
          "text": "<p><span style=\"font-size:12.0pt;\">To decrease the occurrence of constipation or diarrhea</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 45-year-old woman had been self-medicating for heartburn. The preparation she was using was a combination of magnesium hydroxide and aluminum hydroxide. Which of the following reasons best explains why many antacid preparations on the market contain a combination of these two antacids instead of a single product?</span></p>",
      "unique_key": "DT1293089",
      "question_audio": null,
      "question_video": null,
      "map_id": 1293089,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p>Because <u>magnesium hydroxide tends to cause diarrhea</u> and <u>aluminum hydroxide tends to cause constipation</u>, a combination of the two can have a balanced effect on intestinal motility without any loss of antacid effectiveness.</p>\r\n<p><strong>Antacid combinations:</strong></p>\r\n<p>These may be superior to any single agent on the following accounts:</p>\r\n<ol style=\"list-style-type: lower-alpha;\">\r\n<li><strong><u>Fast (Mag. hydrox.) and slow (Alum. hydrox.)</u></strong> acting components yield prompt as well as sustained effect.</li>\r\n<li><strong>Mag. salts are laxative, while alum. Salts are constipating:</strong> <u>combination may annul each other's action and bowel movement may be least affected.</u></li>\r\n<li><u>Gastric emptying is least affected; while alum. salts tend to delay it, mag./cal. Salts tend to hasten it.</u></li>\r\n<li><strong>Dose of individual components is reduced; systemic toxicity (dependent on fractional absorption) is minimized.</strong></li>\r\n</ol>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202412201fdbc4a5-4788-4565-bde7-c2b19d2aaf02.jpg\">\r\n<p><strong>Option A:</strong> Antacid preparations have <strong>no bactericidal effect</strong> on Helicobacter pylori.</p>\r\n<p><strong>Option B: Overdose toxicity is extremely rare</strong> because intestinal absorption of these drugs is negligible.</p>\r\n<p><strong>Option C:</strong> Because magnesium hydroxide tends to increase gastric emptying, and aluminum hydroxide tends to do the opposite, the <strong>combination actually has little effect on gastric emptying.</strong></p>\r\n<p><strong><u>Key Takeaway:</u></strong></p>\r\n<ul>\r\n<li><strong>Because <u>magnesium hydroxide tends to cause diarrhea</u> and <u>aluminum hydroxide tends to cause constipation</u>,</strong> a combination of the two can have a balanced effect on intestinal motility without any loss of antacid effectiveness.</li>\r\n</ul>",
      "correct_choice_id": 74,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9,
      "choices": [
        {
          "id": 81,
          "text": "<p><span style=\"font-size:12.0pt;\">Ondansetron</span></p>"
        },
        {
          "id": 82,
          "text": "<p><span style=\"font-size:12.0pt;\">Loperamide</span></p>"
        },
        {
          "id": 83,
          "text": "<p><span style=\"font-size:12.0pt;\">Metoclopramide</span></p>"
        },
        {
          "id": 84,
          "text": "<p><span style=\"font-size:12.0pt;\">Famotidine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 64-year-old woman suffering from episodic heartburn routinely took an over-the-counter medication as needed. The drug acts by inhibiting the action of an endogenous compound released from enterochromaffin-like cells of the stomach. Which of the following drugs did the patient most likely take?</span></p>",
      "unique_key": "DT1293091",
      "question_audio": null,
      "question_video": null,
      "map_id": 1293091,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Heartburn is caused by gastroesophageal reflux disease (GERD).</strong></p>\r\n<p>Drugs for <strong>heartburn act by decreasing the secretion of acid or neutralizing hydrochloric acid in the stomach.</strong></p>\r\n<p>They include</p>\r\n<ul>\r\n<li>Antacids,</li>\r\n<li>H2 antagonists,</li>\r\n<li>Proton pump inhibitors.</li>\r\n<li>H2 antagonists such as <u>famotidine block H2 receptors, thus inhibiting the action of histamine that is released from enterochromaffin-like cells</u> located on the stomach wall.</li>\r\n</ul>\r\n<p><strong><u>Summary of drugs used for acid-peptic disease</u></strong></p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20241220112ca2a4-8e7d-41e3-bb9d-72ab72ef40db.jpg\">\r\n<p><strong>Option A:</strong> Ondansetron, 5HT3 Antagonist used in chemotherapy induced vomiting.</p>\r\n<p><strong>Option B:</strong> Loperamide, Mu Agonist Used in Diarrhea.</p>\r\n<p><strong>Option C:</strong> Metoclorpromide, D2 Blocker used in nausea &amp; Vomiting.</p>\r\n<p><strong><u>Key Takeaway:</u></strong></p>\r\n<ul>\r\n<li>H2 antagonists such as <strong><u>famotidine block H2 receptors, thus inhibiting the action of histamine that is released from enterochromaffin-like cells</u></strong> located on the stomach wall.</li>\r\n</ul>",
      "correct_choice_id": 84,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10,
      "choices": [
        {
          "id": 91,
          "text": "<p><span style=\"font-size:12.0pt;\">Ranitidine</span></p>"
        },
        {
          "id": 92,
          "text": "<p><span style=\"font-size:12.0pt;\">Omeprazole</span></p>"
        },
        {
          "id": 93,
          "text": "<p><span style=\"font-size:12.0pt;\">Sucralfate</span></p>"
        },
        {
          "id": 94,
          "text": "<p><span style=\"font-size:12.0pt;\">Metoclopramide</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 36-year-old man complained to his physician of dizziness and drowsiness. The man, recently diagnosed with gastroesophageal reflux disease, had started an appropriate treatment 2 weeks earlier. Laboratory findings showed an increase of the patient's prolactin levels. Which of the following drugs could have caused the signs and symptoms of this patient?</span></p>",
      "unique_key": "DT1293094",
      "question_audio": null,
      "question_video": null,
      "map_id": 1293094,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p>Metoclopramide is an <strong>antagonist of D2 and 5-HT3 receptors</strong>.</p>\r\n<p><strong>Blockade of D2 receptors in the central nervous system can cause dizziness and drowsiness</strong></p>\r\n<p><strong>Blockade of D2 receptors in the pituitary leads to hyperprolactinemia</strong>, a common adverse effect of metoclopramide</p>\r\n<p><strong>Side effects of Metoclopramide:</strong></p>\r\n<ul>\r\n<li>Sedation,</li>\r\n<li>Dizziness,</li>\r\n<li>Loose stools,</li>\r\n<li>Muscle dystonias (especially in children)</li>\r\n</ul>\r\n<p><strong><u>Long-term use can cause parkinsonism, galactorrhoea and gynaecomastia.</u></strong></p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20241220abfc9427-bbaf-4b86-883b-0a95a3aa00d2.jpg\">\r\n<p><strong>Option A, B &amp; C:</strong> All of these do not block <strong>D2 receptors hence they do not lead to typical side effects of Metoclopramide</strong></p>\r\n<p><strong><u>Key Takeaway:</u></strong></p>\r\n<ul>\r\n<li>Blockade of D2 receptors in the pituitary by metoclopramide leads to hyperprolactinemia in the short term. It can also cause parkinsonism, galactorrhoea and gynaecomastia in long term.</li>\r\n</ul>",
      "correct_choice_id": 94,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11,
      "choices": [
        {
          "id": 101,
          "text": "<p><span style=\"font-size:12.0pt;\">Pulmonary fibrosis</span></p>"
        },
        {
          "id": 102,
          "text": "<p><span style=\"font-size:12.0pt;\">Ischemic colitis</span></p>"
        },
        {
          "id": 103,
          "text": "<p><span style=\"font-size:12.0pt;\">Ischemic heart disease</span></p>"
        },
        {
          "id": 104,
          "text": "<p><span style=\"font-size:12.0pt;\">Muscle rigidity and tremor</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 65-year-old woman came to the medicine department seeking treatment for her irritable bowel syndrome with recurrent episodes of abdominal pain, flatulence and diarrhea that are not relieved by loperamide. Her physician has added alosetron for the further control of diarrhoea. Which adverse effect may result from taking the given drug for this condition?</span></p>",
      "unique_key": "DT1293097",
      "question_audio": null,
      "question_video": null,
      "map_id": 1293097,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Alosetron is used to treat diarrhea-predominant IBS, but it may uncommonly cause ischemic colitis.</strong></p>\r\n<p>The <strong>most serious adverse reactions are constipation and ischemic colitis</strong></p>\r\n<p>Other adverse reactions include <strong>nausea and vomiting, GI discomfort and pain, diarrhea, flatulence, hemorrhoids, and others</strong>.</p>\r\n<p><strong><u>Symptomatic management of Irritable Bowel Syndrome</u></strong></p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20241220dd1f775d-a9de-4658-a9af-9b1a12861f59.jpg\">\r\n<p><strong>Option A,B &amp; C:</strong> It is <strong>not associated</strong> with pulmonary fibrosis, ischemic heart disease, muscle rigidity and tremor.</p>\r\n<p><strong><u>Key Takeaway:</u></strong></p>\r\n<ul>\r\n<li>Alosetron is used to treat diarrhea-predominant IBS, but it may uncommonly cause <strong>ischemic colitis.</strong></li>\r\n</ul>",
      "correct_choice_id": 102,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12,
      "choices": [
        {
          "id": 111,
          "text": "<p><span style=\"font-size:12.0pt;\">Prucalopride</span></p>"
        },
        {
          "id": 112,
          "text": "<p><span style=\"font-size:12.0pt;\">Alvimopan</span></p>"
        },
        {
          "id": 113,
          "text": "<p><span style=\"font-size:12.0pt;\">Linaclotide</span></p>"
        },
        {
          "id": 114,
          "text": "<p><span style=\"font-size:12.0pt;\">Ivacaftor</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">An experimental new drug L has been developed & approved for constipation-predominant irritable bowel syndrome. Based on the mechanism of action shown in the image, drug L is likely to be which of the following drug?<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202412206f8612df-1a7b-4c12-982c-934b58ea89c3.jpg\"></span></p>",
      "unique_key": "DT1293098",
      "question_audio": null,
      "question_video": null,
      "map_id": 1293098,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Linaclotide:</strong></p>\r\n<p><strong>Linaclotide</strong> is a <strong>secretory agent</strong></p>\r\n<p>&darr; </p>\r\n<p>A 14-amino acid peptide <strong>agonist of the membrane-spanning GC-C</strong>.</p>\r\n<p>&darr; </p>\r\n<p>In the intestinal epithelium, <strong>GC-C is activated by linaclotide</strong>.</p>\r\n<p>&darr; </p>\r\n<p><strong>Activation of GC-C results in increased synthesis of cyclic GMP</strong></p>\r\n<p>&darr; </p>\r\n<p>Resulting in <strong>enhanced chloride and bicarbonate secretion</strong> into the intestinal lumen</p>\r\n<p>&darr; </p>\r\n<p>Leading in turn to <strong>water secretion and enhanced motility</strong>.</p>\r\n<p>This <strong>compound is approved in the treatment</strong> of</p>\r\n<ul>\r\n<li>Constipation-predominant IBS and</li>\r\n<li>Chronic constipation</li>\r\n</ul>\r\n<p>Common side effects</p>\r\n<ul>\r\n<li>Diarrhea</li>\r\n<li>Gas</li>\r\n<li>Abdominal pain</li>\r\n<li>Headaches</li>\r\n</ul>\r\n<p><strong>Linaclotide is contraindicated in children under 6 years old.</strong></p>\r\n<p><strong>Option A:</strong> Prucalopride is <strong>5-HT4 agonist drugs</strong> with no action on D2 receptors (no antiemetic property). These drugs increase whole GI motility including colon.</p>\r\n<p><strong>Option B:</strong> Alvimopan is a <strong>peripheral opioid antagonist</strong> developed for paralytic ileus.</p>\r\n<p><strong>Option D:</strong> Ivacaftor is <strong>CFTR stimulator and Potentiator</strong> used for cystic fibrosis</p>\r\n<p><strong><u>Key Takeaway:</u></strong></p>\r\n<ul>\r\n<li>Constipation in IBS patients can be managed by <strong>linaclotide</strong> (a guanylate cyclase-C agonist) <strong>stimulates chloride secretion</strong> in GIT that induces passive movement of sodium and water into the bowel lumen.</li>\r\n</ul>",
      "correct_choice_id": 113,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13,
      "choices": [
        {
          "id": 121,
          "text": "<p><span style=\"font-size:12.0pt;\">Mesalamine</span></p>"
        },
        {
          "id": 122,
          "text": "<p><span style=\"font-size:12.0pt;\">Daclizumab</span></p>"
        },
        {
          "id": 123,
          "text": "<p><span style=\"font-size:12.0pt;\">Dexamethasone</span></p>"
        },
        {
          "id": 124,
          "text": "<p><span style=\"font-size:12.0pt;\">Infliximab</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 45-year-old man recently diagnosed with mild colonic Crohn disease had been receiving sulfasalazine for 4 weeks, but remission was not achieved. Prednisone was added for another 2 weeks, but improvement was negligible, and the gastroenterologist decided to add a third drug to the therapy. Which of the following drugs would be appropriate for the patient at this time?</span></p>",
      "unique_key": "DT1293099",
      "question_audio": null,
      "question_video": null,
      "map_id": 1293099,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p>Treatment of <strong>mild colonic Crohn disease can start with sulfasalazine or glucocorticoids.</strong> If <strong>remission is not achieved, infliximab, azathioprine, or methotrexate is added.</strong></p>\r\n<p>An <strong><u>important proinflammatory cytokine in Crohn disease is tumor necrosis factor (TNF).</u></strong></p>\r\n<p><strong>Infliximab is a monoclonal antibody that binds to soluble and membrane-bound TNF with high affinity</strong>, thus preventing the binding of the cytokine to its receptors.</p>\r\n<p><strong>Infliximab: It is a chimeric anti-TNF&alpha; antibody that is indicated in</strong></p>\r\n<ul>\r\n<li><strong><u>Severe active Crohn's disease,</u></strong></li>\r\n<li><strong><u>Fistulating Crohn's disease and</u></strong></li>\r\n<li><strong><u>Severe Ulcerative colitis</u></strong> which has not improved with i.v. corticosteroids and immunosuppressants, or when the latter are inappropriate.</li>\r\n</ul>\r\n<p>It is only a <strong><u>reserve drug for selected patients with refractory disease</u></strong>.</p>\r\n<p><strong>Option A &amp; C:</strong> Can't be given, <strong>as prednisone and sulfasalazine were not effective.</strong></p>\r\n<p><strong>Option B:</strong> Daclizumab is a monoclonal antibody used only for the treatment of <strong>acute organ rejection.</strong></p>\r\n<p><strong><u>Key Takeaway:</u></strong></p>\r\n<ul>\r\n<li>Infliximab is a chimeric <strong>anti-TNF&alpha; antibody</strong> that is indicated in <strong>Severe active Crohn's</strong> disease, <strong>Fistulating Crohn's</strong> disease and <strong>Severe Ulcerative colitis</strong> which has not improved with i.v. corticosteroids and immunosuppressants, or when the latter are inappropriate.</li>\r\n</ul>",
      "correct_choice_id": 124,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14,
      "choices": [
        {
          "id": 131,
          "text": "<p><span style=\"font-size:12.0pt;\">Nn cholinergic</span></p>"
        },
        {
          "id": 132,
          "text": "<p><span style=\"font-size:12.0pt;\">5-HT3 serotonergic</span></p>"
        },
        {
          "id": 133,
          "text": "<p><span style=\"font-size:12.0pt;\">Mu opioid</span></p>"
        },
        {
          "id": 134,
          "text": "<p><span style=\"font-size:12.0pt;\">M3 cholinergic</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 45-year-old woman presented to her physician with a history of painless diarrhea that was urgent and usually occurred during meals since 2-3 weeks. After physical examination, laboratory tests, and colonoscopy, a diagnosis of irritable bowel syndrome was made, and the woman was prescribed an appropriate therapy that included loperamide. Direct activation of which of the following receptors most likely mediated the therapeutic effect of the drug in this patient?</span></p>",
      "unique_key": "DT1293100",
      "question_audio": null,
      "question_video": null,
      "map_id": 1293100,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Loperamide is an opioid agonist that directly activates mu (&mu;) receptors in the enteric nervous system</strong>.</p>\r\n<p>This activation of enteric neurons and smooth muscle ultimately causes a <strong>decrease in the contraction of intestinal longitudinal muscle and a marked increase in contraction of circular muscle</strong>.</p>\r\n<p>Therefore, <strong>propulsive peristaltic waves are diminished, and tone is increased, thus relieving diarrhea</strong>.</p>\r\n<p><strong><u>Symptomatic management of Irritable Bowel Syndrome</u></strong></p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202412209a126297-2443-45bb-9792-0564370546e1.jpg\">\r\n<p>Option A : Nicotine &amp; Varenicline acts via Nn Cholinergic Receptors.</p>\r\n<p>Option B : 5HT 3 Antagonists are used in Chemotherapy induced Vomiting, not related to IBS.</p>\r\n<p>Option C : M3 Antagonists are used in Overactive bladder. Not related to IBS.</p>\r\n<p><strong><u>Key Takeaway:</u></strong></p>\r\n<ul>\r\n<li>Loperamide is an opioid agonist that directly activates <strong>mu (&mu;)</strong> receptors in the enteric nervous system <strong>decreasing peristaltic movement and controlling diarrhoea.</strong></li>\r\n</ul>",
      "correct_choice_id": 133,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15,
      "choices": [
        {
          "id": 141,
          "text": "<p><span style=\"font-size:12.0pt;\">Palonosetron, dexamethasone, and aprepitant</span></p>"
        },
        {
          "id": 142,
          "text": "<p><span style=\"font-size:12.0pt;\">Dexamethasone</span></p>"
        },
        {
          "id": 143,
          "text": "<p><span style=\"font-size:12.0pt;\">Dexamethasone and aprepitant</span></p>"
        },
        {
          "id": 144,
          "text": "<p><span style=\"font-size:12.0pt;\">Palonosetron</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 45-year-old male patient undergoing cancer chemotherapy with cisplatin is placed on medication to prevent acute emesis. Which of the following combination of drugs is recommended for this purpose in current guidelines?</span></p>",
      "unique_key": "DT1293101",
      "question_audio": null,
      "question_video": null,
      "map_id": 1293101,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p>Current guidelines in Cancer recommend a <strong>three drug combination to prevent acute emesis with highly emetogenic drugs such as cisplatin</strong>.</p>\r\n<p>The combination should include a</p>\r\n<ul>\r\n<li><strong>Serotonin 5-HT3 antagonist along with </strong></li>\r\n<li><strong>Dexamethasone and </strong></li>\r\n<li><strong>Aprepitant</strong></li>\r\n</ul>\r\n<p>In patients who <u>do not obtain optimum protection by ondansetron alone</u>, addition of <u>dexamethasone, promethazine/diazepam or both, <strong>dexamethasone + NK1 antagonist aprepitant enhances antiemetic efficacy.</strong></u></p>\r\n<p>Adjuvant drugs are more often required for delayed phase vomiting that occurs on the second to fifth day of cisplatin therapy, in some, but not all patients.</p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/2024122020d085fa-28fc-4618-9759-5f74f18f97ee.jpg\">\r\n<p>Option B, C &amp; D: Current guidelines in Cancer recommend a <strong>three drug combination consisting of Serotonin 5-HT3 antagonist along with Dexamethasone and Aprepitant to prevent acute emesis with highly emetogenic drugs such as cisplatin</strong>. So Single or two Drug Combinations are inferior choices.</p>\r\n<p><strong><u>Key Takeaway:</u></strong></p>\r\n<ul>\r\n<li>Cisplatin induced vomiting can be controlled with <strong>combinations of Serotonin 5-HT3 antagonist along with Dexamethasone and Aprepitant.</strong></li>\r\n</ul>",
      "correct_choice_id": 141,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16,
      "choices": [
        {
          "id": 151,
          "text": "<p><span style=\"font-size:12.0pt;\">Metoclopramide</span></p>"
        },
        {
          "id": 152,
          "text": "<p><span style=\"font-size:12.0pt;\">Ondansetron</span></p>"
        },
        {
          "id": 153,
          "text": "<p><span style=\"font-size:12.0pt;\">Meclizine</span></p>"
        },
        {
          "id": 154,
          "text": "<p><span style=\"font-size:12.0pt;\">Promethazine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 54-year-old man with a 70-80 pack/year history of tobacco abuse and chronic alcohol abuse has developed carcinoma of the larynx. His treatment includes concurrent high-dose cisplatin and radiation therapy. He has developed significant nausea and vomiting. Which would be the best agent to treat these side effects?</span></p>",
      "unique_key": "DT1293103",
      "question_audio": null,
      "question_video": null,
      "map_id": 1293103,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong><u>Ondansetron is a 5-HT3 antagonist</u></strong> that is <u>highly effective in the treatment of cisplatin-induced chemotherapy, better so than metoclopramide.</u></p>\r\n<p><strong><u>Chemotherapy induced Nausea and vomiting (CINV)</u></strong></p>\r\n<p>Chemoreceptor Trigger Zone (CTZ) gets stimulated after chemotherapy.</p>\r\n<p><strong>CTZ has various receptors:</strong></p>\r\n<ol>\r\n<li>5HT3 - increases nausea vomiting</li>\r\n<li>NK1 - increases nausea vomiting</li>\r\n<li>D2 - increases nausea vomiting</li>\r\n<li>CB1 - decreases nausea and vomiting</li>\r\n</ol>\r\n<p><strong>Most emetogenic chemotherapeutic agent is Cisplatin</strong></p>\r\n<p>Least emetogenic chemotherapeutic agent is Chlorambucil.</p>\r\n<p><strong><u>Drug of choice for CINV:</u></strong></p>\r\n<p><strong><u>5HT3 antagonist</u></strong></p>\r\n<ul>\r\n<li>Ondansetron,</li>\r\n<li>Granisetron,</li>\r\n<li>Ramosetron,</li>\r\n<li>Palonosetron</li>\r\n</ul>\r\n<p>They are <strong><u>the drug of choice in early phase CINV upto 24 hours</u></strong> [not in delayed phase CINV after 24 hours]</p>\r\n<p><strong>Palonosetron being the longest acting is effective in the delayed phase.</strong></p>\r\n<p><strong>Side effect:</strong> Constipation.</p>\r\n<p>Option A: <strong><u>Ondansetron is a 5-HT3 antagonist</u></strong> that is <u>highly effective in the treatment of cisplatin-induced chemotherapy which occurs mainly due to 5HT3 Stimulation, So Better than metoclopramide.</u></p>\r\n<p><strong>Option C &amp; D:</strong></p>\r\n<p><u>Both meclizine and promethazine are antagonists of H1-receptors used in the treatment of motion sickness, true vertigo, and pregnancy-associated nausea.</u></p>\r\n<p><strong><u>Key Takeaway:</u></strong></p>\r\n<ul>\r\n<li><strong>Ondansetron is a 5-HT3 antagonist</strong> that is highly effective in the <u>treatment of cisplatin-induced chemotherapy</u>, better so than metoclopramide.</li>\r\n</ul>",
      "correct_choice_id": 152,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 17,
      "choices": [
        {
          "id": 161,
          "text": "<p><span style=\"font-size:12.0pt;\">Histamine H2 receptor blockade</span></p>"
        },
        {
          "id": 162,
          "text": "<p><span style=\"font-size:12.0pt;\">Muscarinic receptor blockade</span></p>"
        },
        {
          "id": 163,
          "text": "<p><span style=\"font-size:12.0pt;\">Dopamine D2 receptor blockade</span></p>"
        },
        {
          "id": 164,
          "text": "<p><span style=\"font-size:12.0pt;\">&alpha;-adrenoceptor activation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 45-year-old male patient with chronic heartburn caused by gastric acid reflux is placed on a drug that increases lower esophageal sphincter tone. Which of the following mechanisms is responsible for this pharmacologic effect?</span></p>",
      "unique_key": "DT1293104",
      "question_audio": null,
      "question_video": null,
      "map_id": 1293104,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20241220aec8ebf1-870e-483d-945c-eed48d4efed6.jpg\">\r\n<p>Metoclopramide <strong>increases lower esophageal sphincter tone by directly blocking dopamine D2 receptors</strong> and <u>increasing acetylcholine release, thereby activating muscarinic receptors in esophageal muscle</u>.</p>\r\n<p>Metoclopramide acts through both dopaminergic and serotonergic Receptors</p>\r\n<p><strong><u>(a) D2 antagonism</u></strong></p>\r\n<p>Dopamine (acting through D2 receptors) is an <u>inhibitory transmitter in the g.i.t.</u></p>\r\n<ul>\r\n<li><u>Delays gastric emptying.</u></li>\r\n<li><u>Causes gastric dilatation and</u></li>\r\n<li><u>Lower esophageal sphincter relaxation, attending nausea and vomiting.</u></li>\r\n</ul>\r\n<p><strong><u>Metoclopramide blocks D2 receptors and has an opposite effect</u></strong></p>\r\n<ul>\r\n<li><strong>Hastening gastric emptying and</strong></li>\r\n<li><strong>Enhancing lower esophageal sphincter tone by augmenting Ach release</strong></li>\r\n</ul>\r\n<p>The <strong>central antidopaminergic (D2) action of metoclopramide on CTZ is clearly responsible for its antiemetic property</strong>.</p>\r\n<p><strong><u>(b) 5-HT4 agonism</u></strong></p>\r\n<p>Metoclopramide acts in the g.i.t. to enhance ACh release from myenteric motor neurones.</p>\r\n<p><strong>The gastric hurrying and LES tonic effects of metoclopramide are mainly due to this action which is synergised by bethanechol and attenuated by atropine.</strong></p>\r\n<p><strong><u>(c) 5-HT3 antagonism</u></strong></p>\r\n<p><strong>At high concentrations, metoclopramide can block 5-HT3</strong> receptors present on inhibitory myenteric interneurons and in the NTS/CTZ.</p>\r\n<p><strong>Option A, B &amp; D:</strong> Metoclopramide acts via Dopaminergic &amp; Serotonergic Receptors so Histaminergic, Muscarinic &amp; Alpha Receptors activation are False Options.</p>\r\n<p><strong><u>Key Takeaway:</u></strong></p>\r\n<ul>\r\n<li>Prokinetic drugs like metoclopramide <strong>increase lower esophageal sphincter tone by directly blocking dopamine D2 receptors responsible for effect in GERD patients.</strong></li>\r\n</ul>",
      "correct_choice_id": 163,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18,
      "choices": [
        {
          "id": 171,
          "text": "<p><span style=\"font-size:12.0pt;\">ACh receptors in the periphery</span></p>"
        },
        {
          "id": 172,
          "text": "<p><span style=\"font-size:12.0pt;\">Dopamine receptors in the CTZ</span></p>"
        },
        {
          "id": 173,
          "text": "<p><span style=\"font-size:12.0pt;\">Glucocorticoid receptors in the vomiting centre</span></p>"
        },
        {
          "id": 174,
          "text": "<p><span style=\"font-size:12.0pt;\">5-HT 3 receptors in the CTZ</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 56-year-old woman has nausea due to chemotherapy for breast cancer. Her physician has prescribed her Droperidol for the same. Droperidol is effective in reducing nausea by blocking which of the following receptors?</span></p>",
      "unique_key": "DT1293105",
      "question_audio": null,
      "question_video": null,
      "map_id": 1293105,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Droperidol is a <u>dopamine-receptor antagonist</u> that diminishes the activity of the CTZ. It is effective in reducing nausea associated with chemotherapy or radiotherapy.</strong></p>\r\n<p><strong><u>Butyrophenones for postoperative nausea and vomiting [PONV]</u></strong></p>\r\n<ul>\r\n<li><strong><u>Droperidol is used for the treatment of PONV</u></strong></li>\r\n<li><strong><u>Haloperidol is used as an adjunctive agent for nausea and vomiting in a palliative setting in cancer patients and for the acute treatment of cannabinoid hyperemesis syndrome</u></strong> (off-label).</li>\r\n</ul>\r\n<p><strong>Potential adverse effects include</strong></p>\r\n<ul>\r\n<li><strong>QT prolongation,</strong></li>\r\n<li>Sedation,</li>\r\n<li>Extrapyramidal symptoms,</li>\r\n<li><strong>Neuroleptic malignant syndrome</strong>, and</li>\r\n<li>Hypotension</li>\r\n</ul>\r\n<p>Option A, C &amp; D: Droperidol is a dopamine-receptor antagonist that diminishes the activity of the CTZ. It is effective in reducing nausea associated with chemotherapy or radiotherapy. So Rest 3 are Incorrect Options.</p>\r\n<p><strong><u>Key Takeaway:</u></strong></p>\r\n<ul>\r\n<li>Droperidol is a <u>dopamine-receptor antagonist</u> that diminishes the activity of the CTZ and is effective in reducing nausea associated with chemotherapy or radiotherapy.</li>\r\n</ul>",
      "correct_choice_id": 172,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19,
      "choices": [
        {
          "id": 181,
          "text": "<p><span style=\"font-size:12.0pt;\">Metoclopramide</span></p>"
        },
        {
          "id": 182,
          "text": "<p><span style=\"font-size:12.0pt;\">Meclizine</span></p>"
        },
        {
          "id": 183,
          "text": "<p><span style=\"font-size:12.0pt;\">Ondansetron</span></p>"
        },
        {
          "id": 184,
          "text": "<p><span style=\"font-size:12.0pt;\">Scopolamine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 56-year-old female patient with ovarian cancer was on cisplatin therapy. She presented to the hospital with several episodes of vomiting. She was inadvertently given an anti-emetic agent. After giving an antiemetic drug, the patient developed dystonia. Which of the following anti-emetic drug most likely to be responsible for these features?</span></p>",
      "unique_key": "DT1293106",
      "question_audio": null,
      "question_video": null,
      "map_id": 1293106,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><u>Metoclopramide by blocking Dopamine D2 receptors, is associated with acute muscular dystonia.</u></p>\r\n<p>Metoclopramide is an <strong>antagonist of D2 and 5-HT3 receptors</strong>.</p>\r\n<p><strong>Blockade of D2 receptors in the central nervous system can cause dizziness and drowsiness</strong></p>\r\n<p><strong>Blockade of D2 receptors in the pituitary leads to hyperprolactinemia</strong>, a common adverse effect of metoclopramide</p>\r\n<p><strong>Side effects of Metoclopramide:</strong></p>\r\n<ul>\r\n<li>Sedation,</li>\r\n<li>Dizziness,</li>\r\n<li>Loose stools,</li>\r\n<li><strong><u>Muscle dystonias</u></strong> (especially in children)</li>\r\n</ul>\r\n<p><strong><u>Long-term use can cause parkinsonism, galactorrhoea and gynaecomastia.</u></strong></p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20241220df3badac-bd19-46fa-acae-032eedc436df.jpg\">\r\n<p><strong>Option B, C &amp; D:</strong> All of them are not D2 receptor blockers. Hence they won't produce acute muscular dystonia.</p>\r\n<p><strong><u>Key Takeaway:</u></strong></p>\r\n<ul>\r\n<li>Metoclopramide by blocking Dopamine D2 receptors, is associated with acute muscular dystonia.</li>\r\n</ul>",
      "correct_choice_id": 181,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20,
      "choices": [
        {
          "id": 191,
          "text": "<p><span style=\"font-size:12.0pt;\">Gastrin</span></p>"
        },
        {
          "id": 192,
          "text": "<p><span style=\"font-size:12.0pt;\">Octreotide</span></p>"
        },
        {
          "id": 193,
          "text": "<p><span style=\"font-size:12.0pt;\">Sulfasalazine</span></p>"
        },
        {
          "id": 194,
          "text": "<p><span style=\"font-size:12.0pt;\">Bismuth subsalicylate</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 65-year-old man presents to his family physician with a 3-month history of watery diarrhea. He is referred to a gastroenterologist, who finds that the patient is also hypokalemic and achlorhydric and has an elevated serum level of vasoactive intestinal peptide due to a pancreatic islet cell tumor (VIPoma). Which of the following agent would be best to treat the patient's symptoms?</span></p>",
      "unique_key": "DT1293107",
      "question_audio": null,
      "question_video": null,
      "map_id": 1293107,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Octreotide is used in the <u>treatment of endocrine tumors</u> such as gastrinomas, glucagonomas, and VIPomas <u>to help alleviate diarrhea.</u></strong></p>\r\n<p><strong>Octreotide</strong></p>\r\n<p>It is a <strong>synthetic surrogate of somatostatin</strong> is <u>40 times more potent in suppressing GH secretion and longer acting.</u></p>\r\n<p>It is <u>preferred over somatostatin for acromegaly and secretory diarrhoeas associated with carcinoid, AIDS, cancer chemotherapy or diabetes.</u></p>\r\n<p><strong>Control of diarrhoea is due to suppression of hormones which enhance intestinal mucosal secretion.</strong></p>\r\n<p><strong><u>Anti - Secretory Drugs for different Diarrheas</u></strong></p>\r\n<ol>\r\n<li><strong>Octreotide</strong> - Drug of choice for\r\n<ul>\r\n<li>Secretory diarrhea</li>\r\n<li>Carcinoid tumor</li>\r\n<li>Vipoma</li>\r\n<li>HIV induced diarrhoea</li>\r\n<li>Cancer induced diarrhoea</li>\r\n</ul>\r\n</li>\r\n<li><strong>Crofelemer</strong> &rarr; (-) CFTR (Decreases Chloride secretion)\r\n<ul>\r\n<li>[CFTR= Cystic fibrosis transmembrane conductance regulator]</li>\r\n<li><strong>Use : Octreotide resistant HIV induced diarrhea.</strong></li>\r\n</ul>\r\n</li>\r\n<li><strong>Aloserton</strong> &rarr; 5HT3 Antagonist\r\n<ul>\r\n<li><strong>Given in Diarrhea predominant-irritable bowel syndrome</strong> [only in females].</li>\r\n<li><strong><u>Increase Risk of Ischemic colitis</u></strong></li>\r\n</ul>\r\n</li>\r\n<li><strong>Trilostane</strong> &rarr; Inhibition of Serotonin synthesis\r\n<ul>\r\n<li><strong>Use : Octreotide resistant carcinoid tumor</strong></li>\r\n</ul>\r\n</li>\r\n<li><strong>Racecadotril:</strong> Enkephalinase inhibitor &rarr; Increase Enkephalins (endogenous opioids)\r\n<ul>\r\n<li><strong>Use : Acute diarrhea in children</strong></li>\r\n</ul>\r\n</li>\r\n</ol>\r\n<p><strong>Option A:</strong> Gastrin is a GI hormone</p>\r\n<p><strong>Option C:</strong> Sulfasalazine is used to treat such inflammatory bowel disease, such as Crohn's disease.</p>\r\n<p><strong>Option D:</strong> Bismuth subsalicylate is used to treat traveler's diarrhea. Which can cause Reye's syndrome.</p>\r\n<p><strong><u>Key Takeaway:</u></strong></p>\r\n<ul>\r\n<li>Octreotide is a preferred drug for acromegaly and secretory diarrhoea associated with carcinoid, AIDS, cancer chemotherapy or diabetes.</li>\r\n</ul>",
      "correct_choice_id": 192,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 21,
      "choices": [
        {
          "id": 201,
          "text": "<p><span style=\"font-size:12.0pt;\">Bisacodyl</span></p>"
        },
        {
          "id": 202,
          "text": "<p><span style=\"font-size:12.0pt;\">Liquid paraffin</span></p>"
        },
        {
          "id": 203,
          "text": "<p><span style=\"font-size:12.0pt;\">Methylcellulose</span></p>"
        },
        {
          "id": 204,
          "text": "<p><span style=\"font-size:12.0pt;\">Bran</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 77-year-old patient presented with weakness, tiredness and muscle cramps. The ECG showed Q-T prolongation, flattening of T wave and occasional A-V block. His serum K+ was low (2.8 mEq/L). He later admitted taking a laxative every day for the past several months. Which of the following laxatives could be responsible for the above condition?</span></p>",
      "unique_key": "DT1293108",
      "question_audio": null,
      "question_video": null,
      "map_id": 1293108,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Patient symptoms of <u>weakness, tiredness and muscle cramps and the ECG showing Q-T prolongation, flattening of T wave and occasional A-V block are all due to hypokalemia due to purgative abuse.</u></strong></p>\r\n<p><strong>Purgative (Bisacodyl) abuse:</strong></p>\r\n<p><u>Purgatives are often self-prescribed and taken without consulting a physician.</u></p>\r\n<p><strong><u>Drawbacks of purgative abuse are:</u></strong></p>\r\n<ul>\r\n<li>Fluid and electrolyte imbalance, especially <strong>hypokalaemia</strong>.</li>\r\n<li>Steatorrhoea, malabsorption syndrome.</li>\r\n<li><strong>Protein losing enteropathy.</strong></li>\r\n<li>Spastic colitis</li>\r\n</ul>\r\n<p><strong>Option B:</strong> Liquid paraffin is stool softener which Carries away fat soluble vitamins with it into the stools: <strong>deficiency may occur</strong> on chronic use.</p>\r\n<p><strong>Option C:</strong> Bulk forming agents can improve stool consistency in patients with colostomy. <strong>Generous amounts of water must be taken with all bulk forming agents.</strong></p>\r\n<p><strong>Option D:</strong> Bran is generally safe, but it is unpalatable, large quantities need to be ingested. Bran should not be used in patients with <strong>gut ulcerations, adhesions, stenosis and when faecal impaction is a possibility.</strong></p>\r\n<p><strong><u>Key Takeaway:</u></strong></p>\r\n<ul>\r\n<li>Chronic use of stimulant purgatives must be discouraged. It is associated with some Drawbacks which are: Fluid and electrolyte imbalance, especially <strong>hypokalaemia</strong> and Steatorrhoea, malabsorption syndrome.</li>\r\n</ul>",
      "correct_choice_id": 201,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 22,
      "choices": [
        {
          "id": 211,
          "text": "<p><span style=\"font-size:12.0pt;\">Docusates</span></p>"
        },
        {
          "id": 212,
          "text": "<p><span style=\"font-size:12.0pt;\">Phenolphthalein</span></p>"
        },
        {
          "id": 213,
          "text": "<p><span style=\"font-size:12.0pt;\">Castor oil</span></p>"
        },
        {
          "id": 214,
          "text": "<p><span style=\"font-size:12.0pt;\">Mag. Sulphate</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 76-year-old male patient came to the medicine department seeking treatment for chronic constipation. His physician suggested long acting purgatives for the same. Which of the following purgatives should not be given due to risk of development of carcinogenicity?</span></p>",
      "unique_key": "DT1293109",
      "question_audio": null,
      "question_video": null,
      "map_id": 1293109,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Phenolphthalein, once among the most popular components of laxatives, has been <u>withdrawn from the market</u> <u>because of potential carcinogenicity.</u></strong></p>\r\n<p><strong>Phenolphthalein:</strong></p>\r\n<ul>\r\n<li>It is a <strong>diphenylmethane derivative that is hydrolyzed by colonic bacteria</strong> to its active form and acts locally only in the colon.</li>\r\n<li>This agent is <strong>only used for bowel cleansing prior to colonoscopy.</strong></li>\r\n<li>Significant adverse reactions include <strong>hypermagnesemia and reduced glomerular filtration rate.</strong></li>\r\n<li>Caution should be exercised in <strong>patients with cardiac arrhythmias and those with renal impairment.</strong></li>\r\n</ul>\r\n<p><strong>Options A, C &amp; D:</strong> All of them are not associated with any sort of carcinogenicity.</p>\r\n<p><strong><u>Key Takeaway:</u></strong></p>\r\n<ul>\r\n<li>Phenolphthalein, once among the most popular components of laxatives, has been <strong><u>withdrawn from the market because of potential carcinogenicity.</u></strong></li>\r\n</ul>",
      "correct_choice_id": 212,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 23,
      "choices": [
        {
          "id": 221,
          "text": "<p><span style=\"font-size:12.0pt;\">Senna</span></p>"
        },
        {
          "id": 222,
          "text": "<p><span style=\"font-size:12.0pt;\">Sorbitol</span></p>"
        },
        {
          "id": 223,
          "text": "<p><span style=\"font-size:12.0pt;\">Castor oil</span></p>"
        },
        {
          "id": 224,
          "text": "<p><span style=\"font-size:12.0pt;\">Bisacodyl</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 39-year-old woman patient with a history of anorexia bulimia which is a binge eating disorder presented to surgical OPD with laxatives abuse for weight loss. Her colonoscopy showed dark brown to black pigmentary deposits in the lining of the large intestine. Histopathology of biopsy revealed pigment laden macrophages within the lamina propria. Which of the following is the most probable laxative agent that is consistent with these findings given below in the image?<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20241220f6b8433e-6608-4c7d-ab32-774259cbabc0.jpg\"></span></p>",
      "unique_key": "DT1293110",
      "question_audio": null,
      "question_video": null,
      "map_id": 1293110,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p>Regular use of senna for more than 6-12 months as purgative causes <u>colonic atony and mucosal pigmentation (melanosis)</u> as shown in the image.</p>\n<p>Senna</p>\n<ul>\n<li>The active principle of Senna stimulates the myenteric plexus to increase peristalsis and decrease segmentation.</li>\n<li>They also promote secretion and inhibit salt and water absorption in the colon.</li>\n<li>Skin rashes, fixed drug eruption are the occasional adverse effects.</li>\n<li>Regular use for 4-12 months causes colonic atony and mucosal pigmentation (melanosis).</li>\n</ul>\n<p>Purgative abuse</p>\n<p><u>Purgatives are often self-prescribed and taken without consulting a physician.</u></p>\n<p><u>Drawbacks of purgative abuse are:</u></p>\n<ul>\n<li>Fluid and electrolyte imbalance, especially hypokalaemia.</li>\n<li>Steatorrhoea, malabsorption syndrome.</li>\n<li>Protein losing enteropathy.</li>\n<li>Spastic colitis</li>\n</ul>\n<p>Options B, C &amp; D: All of them are not associated with melanosis coli.</p>\n<p><u>Key Takeaway:</u></p>\n<ul>\n<li>Chronic use of anthraquinone derivatives (like senna and cascara) may lead to melanosis coli (brown pigmentation of colon).</li>\n</ul>",
      "correct_choice_id": 221,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24,
      "choices": [
        {
          "id": 231,
          "text": "<p><span style=\"font-size:12.0pt;\">Castor oil</span></p>"
        },
        {
          "id": 232,
          "text": "<p><span style=\"font-size:12.0pt;\">Docusate</span></p>"
        },
        {
          "id": 233,
          "text": "<p><span style=\"font-size:12.0pt;\">Magnesium sulfate</span></p>"
        },
        {
          "id": 234,
          "text": "<p><span style=\"font-size:12.0pt;\">Methylcellulose</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 70-year-old woman complained to her physician of obstinate constipation. The physician prescribed a laxative that acts in the colon by absorbing water into the faecal contents, thus promoting peristalsis about 1 or 2 days after administration. Which of the following drugs was most likely prescribed?</span></p>",
      "unique_key": "DT1293111",
      "question_audio": null,
      "question_video": null,
      "map_id": 1293111,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Methylcellulose is an <u>indigestible hydrophilic polysaccharide</u> polymer that absorbs water, forming a bulky gel that <u>distends the intestine, thus stimulating peristaltic activity.</u></strong></p>\r\n<p><strong>Methylcellulose:</strong></p>\r\n<ul>\r\n<li>A <strong>semi-synthetic, colloidal, hydrophilic derivative of cellulose that remains largely unfermented</strong> in the colon.</li>\r\n<li>It is an <u>indigestible hydrophilic polysaccharide polymer</u> that absorbs water, forming a bulky gel that <strong>distends the intestine, thus stimulating peristaltic activity.</strong></li>\r\n<li><strong>Generous amounts of water must be taken with all bulk forming agents.</strong></li>\r\n<li>It <strong>acts mainly in the colon</strong> and <u>takes 1 or 2 days to work.</u></li>\r\n<li><strong>The laxative effect is mild.</strong></li>\r\n</ul>\r\n<p><strong>Options A, C:</strong> Castor oil and docusates are stool softeners.</p>\r\n<p>Option D: Magnesium Sulphate is osmotic purgative.</p>\r\n<p><strong><u>Key Takeaway:</u></strong></p>\r\n<ul>\r\n<li>Methylcellulose is an <u>indigestible hydrophilic polysaccharide</u> polymer that absorbs water, forming a bulky gel that <strong><u>distends the intestine, thus stimulating peristaltic activity.</u></strong></li>\r\n</ul>",
      "correct_choice_id": 234,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 25,
      "choices": [
        {
          "id": 241,
          "text": "<p><span style=\"font-size:12.0pt;\">Omeprazole</span></p>"
        },
        {
          "id": 242,
          "text": "<p><span style=\"font-size:12.0pt;\">Lactulose</span></p>"
        },
        {
          "id": 243,
          "text": "<p><span style=\"font-size:12.0pt;\">Loperamide</span></p>"
        },
        {
          "id": 244,
          "text": "<p><span style=\"font-size:12.0pt;\">Sucralfate</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 58-year-old alcoholic man suffering from hepatic cirrhosis was admitted to the hospital because of drowsiness and disorientation in time and place. Further examinations led to the diagnosis of portal-systemic encephalopathy. Which of the following drugs would be appropriate to eliminate toxic enteric products in this patient?</span></p>",
      "unique_key": "DT1293112",
      "question_audio": null,
      "question_video": null,
      "map_id": 1293112,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><u>Eliminating toxic enteric products (mainly fecal ammonia) is a therapeutic goal in portal-systemic encephalopathy</u>.</p>\r\n<p><u>Patients with severe liver disease have an impaired capacity to detoxify ammonia</u> coming from the colon, where it is produced by bacterial metabolism of fecal urea.</p>\r\n<p><strong>Ammonia is an important cause of brain toxicity.</strong> In <strong>patients with hepatic encephalopathy, lactulose causes reduction of blood <u>NH3 concentration by 25-50%.</u></strong></p>\r\n<p><strong><u>Mechanism of Lactulose</u></strong></p>\r\n<p>The <strong>acidic breakdown products of lactulose lower the pH of stools</strong></p>\r\n<p><strong>&darr; </strong></p>\r\n<p><strong>Lower acidic PH is unfavourable to NH3 producing bacteria</strong></p>\r\n<p><strong>&darr; </strong></p>\r\n<p><strong>Ammonia produced by bacteria in the colon is converted to ionized NH4+ salts that are not absorbed</strong>.</p>\r\n<p><strong>&darr; </strong></p>\r\n<p><strong>\"Trapping\" of the ammonia by its conversion to polar ammonium ion which is poorly absorbed.</strong></p>\r\n<p><strong>Options A, C &amp; D: </strong>All of them are not used in cases of hepatic encephalopathy.</p>\r\n<p><strong><u>Key Takeaway: </u></strong></p>\r\n<ul>\r\n<li>Lactulose is used in patients with <strong>hepatic encephalopathy,</strong> in which it causes reduction of blood <strong><u>NH3 concentration by 25-50%.</u></strong></li>\r\n</ul>",
      "correct_choice_id": 242,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}